Kaiser spokesman Jim Anderson argues that if Shaw’s products didn’t make their way to hospitals it was because of “significant supply issues” on Retractable’s end. He also says they were prone to malfunction and that, in several cases, needles detached and were left “stuck in the arms of patients.”
I'm doubtful that a Kaiser spokesman would fabricate these problems, which leads me to believe that perhaps this reporting isn't as balanced as it could be. Maybe these needles are great, but perhaps there are two problems here, one being a competitor with a lot of control over the customers, and a second being problems with supply chain and quality control.
Kaiser spokesman Jim Anderson argues that if Shaw’s products didn’t make their way to hospitals it was because of “significant supply issues” on Retractable’s end. He also says they were prone to malfunction and that, in several cases, needles detached and were left “stuck in the arms of patients.”
I'm doubtful that a Kaiser spokesman would fabricate these problems, which leads me to believe that perhaps this reporting isn't as balanced as it could be. Maybe these needles are great, but perhaps there are two problems here, one being a competitor with a lot of control over the customers, and a second being problems with supply chain and quality control.